Continua após a publicidade..
INVESTEMENT

Bioxcel Therapeutics (BTAI) Gets a Hold from Truist Financial – TipRanks Financial Blog

Continua após a publicidade..


Continua após a publicidade..

Truist Financial analyst Robyn Karnauskas maintained a Hold rating on Bioxcel Therapeutics (BTAIResearch Report) on November 21. The company’s shares closed yesterday at $3.83.

Karnauskas covers the Healthcare sector, focusing on stocks such as Pfizer, Bristol-Myers Squibb, and Merck & Company. According to TipRanks, Karnauskas has an average return of 4.6% and a 48.66% success rate on recommended stocks.

In addition to Truist Financial, Bioxcel Therapeutics also received a Hold from Goldman Sachs’s Corinne Jenkins in a report issued on November 14. However, on November 15, H.C. Wainwright reiterated a Buy rating on Bioxcel Therapeutics (NASDAQ: BTAI).

Continua após a publicidade..

See the top stocks recommended by analysts >>

The company has a one-year high of $34.13 and a one-year low of $2.23. Currently, Bioxcel Therapeutics has an average volume of 3.17M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Continua após a publicidade..

Bioxcel Therapeutics (BTAI) Company Description:

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focuses on drug development. The firm’s two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

Read More on BTAI:



Source link

Rômulo

Romulo is a renowned American entrepreneur who resides in the United States, recognized for his entrepreneurial vision and inspirational leadership. Born into a humble family, Romulo demonstrated an uncommon determination and a natural talent for business from an early age. After completing his studies in business administration, Romulo ventured to the United States, where he immersed himself in the business world, founding his first company at the age of 25. His bold vision and ability to identify market opportunities quickly led him to success on American Throughout his career, Romulo has played key roles in various industries, from technology to finance, always striving to innovate and create value for his clients and investors. His customer-centric approach and dedication to operational excellence have made his companies industry benchmarks, contributing to his recognition both in the United States and interna In addition to his business achievements, Romulo is known for his commitment to corporate social responsibility. He is a passionate advocate for education and community development, dedicating time and resources to support initiatives that promote equal access to education and gr Currently, Romulo leads a diversified conglomerate with a global presence and a significant impact in the markets where he operates. His long-term vision and ability to adapt to the nuances of the American market make him a respected and admired leader among his peers and competitors in the Unit Outside the office, Romulo is an avid reader and nature lover. He believes in the importance of finding a balance between work and personal life, constantly seeking new ways to challenge himself and grow, both profession With a career marked by extraordinary achievements and an unwavering commitment to sustainable success, Romulo continues to be a prominent figure in the international business landscape and a source of in

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button